Pell Bio-Med Technology Co., Ltd. (TPE:6949)
45.35
-4.15 (-8.38%)
Nov 17, 2026, 1:30 PM CST
Pell Bio-Med Technology Market Cap
Pell Bio-Med Technology has a market cap or net worth of 59.43 billion as of November 17, 2026. It is the 6,774th most valuable company in the world and the 178th biggest in Taiwan. Its market cap has increased by 166.99% in one year.
Market Cap
59.43B
Enterprise Value
57.84B
Revenue
32.33M
Global Rank
Country Rank
#178 Taiwan
PE Ratio
n/a
ChartMarket Cap Chart
Since March 8, 2024, Pell Bio-Med Technology's market cap has increased from 5.56B to 59.43B, an increase of 969.58%. That is a compound annual growth rate of 140.86%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 17, 2026 | 59.43B | 196.22% |
| Dec 31, 2025 | 20.06B | 324.81% |
| Dec 31, 2024 | 4.72B | -15.00% |
| Mar 8, 2024 | 5.56B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Lin BioScience | 134.33B |
| Caliway Biopharmaceuticals | 116.34B |
| Oneness Biotech | 22.18B |
| Steminent Biotherapeutics | 21.07B |
| Sunmax Biotechnology | 20.94B |
| CHO Pharma | 18.19B |
| TaiMed Biologics | 17.40B |
| EirGenix | 15.83B |